A phase II clinical trial of the efficacy and safety of short-term (3 days) enoxaparin for the prevention of venous thromboembolism after gastric cancer surgery

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'A phase II clinical trial of the efficacy and safety of short-term (3 days) enoxaparin for the prevention of venous thromboembolism after gastric cancer surgery'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds